507 related articles for article (PubMed ID: 15740491)
1. Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure.
Chen CT; Chu CJ; Wang TF; Lu RH; Lee FY; Chang FY; Lin HC; Chan CC; Wang SS; Huang HC; Lee SD
J Gastroenterol Hepatol; 2005 Mar; 20(3):450-5. PubMed ID: 15740491
[TBL] [Abstract][Full Text] [Related]
2. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of nitric oxide synthase isoforms.
Chu CJ; Chang CC; Wang TF; Lee FY; Chang FY; Chen YC; Chan CC; Huang HC; Wang SS; Lee SD
J Gastroenterol Hepatol; 2006 Jul; 21(7):1194-9. PubMed ID: 16824075
[TBL] [Abstract][Full Text] [Related]
3. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
Hsu CY; Lee FY; Huo TI; Chan CY; Huang HC; Lin HC; Chang CC; Teng TH; Wang SS; Lee SD
J Gastroenterol Hepatol; 2010 Jul; 25(7):1321-8. PubMed ID: 20594263
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
[TBL] [Abstract][Full Text] [Related]
5. Hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of endotoxin and tumor necrosis factor-alpha.
Chu CJ; Chen CT; Wang SS; Lee FY; Chang FY; Lin HC; Wu SL; Lu RH; Chan CC; Huang HC; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jun; 64(6):321-30. PubMed ID: 11534799
[TBL] [Abstract][Full Text] [Related]
6. Prostacyclin inhibition by indomethacin aggravates hepatic damage and encephalopathy in rats with thioacetamide-induced fulminant hepatic failure.
Chu CJ; Hsiao CC; Wang TF; Chan CY; Lee FY; Chang FY; Chen YC; Huang HC; Wang SS; Lee SD
World J Gastroenterol; 2005 Jan; 11(2):232-6. PubMed ID: 15633222
[TBL] [Abstract][Full Text] [Related]
7. Establishment of an animal model of hepatic encephalopathy.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Wu SL; Chan CC; Tsai YT; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):263-9. PubMed ID: 10820904
[TBL] [Abstract][Full Text] [Related]
8. Curcumin ameliorates acute thioacetamide-induced hepatotoxicity.
Shapiro H; Ashkenazi M; Weizman N; Shahmurov M; Aeed H; Bruck R
J Gastroenterol Hepatol; 2006 Feb; 21(2):358-66. PubMed ID: 16509859
[TBL] [Abstract][Full Text] [Related]
9. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure.
Chu CJ; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Huang HC; Lee SD
Eur J Clin Invest; 2001 Feb; 31(2):156-63. PubMed ID: 11168455
[TBL] [Abstract][Full Text] [Related]
10. Hypothyroidism minimizes liver damage and improves survival in rats with thioacetamide induced fulminant hepatic failure.
Bruck R; Oren R; Shirin H; Aeed H; Papa M; Matas Z; Zaidel L; Avni Y; Halpern Z
Hepatology; 1998 Apr; 27(4):1013-20. PubMed ID: 9537441
[TBL] [Abstract][Full Text] [Related]
11. Pravastatin for thioacetamide-induced hepatic failure and encephalopathy.
Huang HC; Chang CC; Wang SS; Chan CY; Lee FY; Chuang CL; Hsin IF; Teng TH; Lin HC; Lee SD
Eur J Clin Invest; 2012 Feb; 42(2):139-45. PubMed ID: 21749370
[TBL] [Abstract][Full Text] [Related]
12. Co-administration of C-Phycocyanin ameliorates thioacetamide-induced hepatic encephalopathy in Wistar rats.
Sathyasaikumar KV; Swapna I; Reddy PV; Murthy ChR; Roy KR; Dutta Gupta A; Senthilkumaran B; Reddanna P
J Neurol Sci; 2007 Jan; 252(1):67-75. PubMed ID: 17169376
[TBL] [Abstract][Full Text] [Related]
13. Modulation of hepatic encephalopathy in rats with thioacetamide-induced acute liver failure by serotonin antagonists.
Yurdaydin C; Herneth AM; Püspök A; Steindl P; Singer E; Ferenci P
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):667-71. PubMed ID: 8853256
[TBL] [Abstract][Full Text] [Related]
14. Role of hepatic nitric oxide synthases in rats with thioacetamide-induced acute liver failure and encephalopathy.
Huang HC; Wang SS; Chan CY; Chen YC; Lee FY; Chang FY; Chu CJ; Lin HC; Lu RH; Lee SD
J Chin Med Assoc; 2007 Jan; 70(1):16-23. PubMed ID: 17276928
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis.
Masubuchi Y; Horie T
Drug Metab Dispos; 2004 Apr; 32(4):437-41. PubMed ID: 15039297
[TBL] [Abstract][Full Text] [Related]
16. Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat.
Chang CC; Wang SS; Huang HC; Chan CY; Lee FY; Lin HC; Nong JY; Chuang CL; Lee SD
Eur J Pharmacol; 2011 Sep; 666(1-3):226-32. PubMed ID: 21575628
[TBL] [Abstract][Full Text] [Related]
17. Brain and plasma levels of opioid peptides are altered in rats with thioacetamide-induced fulminant hepatic failure: implications for the treatment of hepatic encephalopathy with opioid antagonists.
Yurdaydin C; Li Y; Ha JH; Jones EA; Rothman R; Basile AS
J Pharmacol Exp Ther; 1995 Apr; 273(1):185-92. PubMed ID: 7714765
[TBL] [Abstract][Full Text] [Related]
18. Increased benzodiazepine-like activity is neither necessary nor sufficient to explain acute hepatic encephalopathy in the thioacetamide-treated rat.
Widler P; Fisch HU; Schoch P; Zimmermann A; Schläpfer TE; Reichen J
Hepatology; 1993 Dec; 18(6):1459-64. PubMed ID: 8080486
[TBL] [Abstract][Full Text] [Related]
19. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy.
Saran T; Hilgier W; Urbańska EM; Turski WA; Albrecht J
J Neurosci Res; 2004 Feb; 75(3):436-40. PubMed ID: 14743457
[TBL] [Abstract][Full Text] [Related]
20. Evidence against a role for endotoxin in the hyperdynamic circulation of rats with prehepatic portal hypertension.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Wu SL; Chan CC; Tai CC; Lai IN; Lee SD
J Hepatol; 1999 Jun; 30(6):1105-11. PubMed ID: 10406190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
